SMO and cancer: Pharmacological modulation of Hh impacts the major critical features of cancer cells: the proliferation, the migration, and the crosstalk with components of proximal stroma, supporting the use of SMO inhibitors such as sonidegib and vismodegib for melanoma therapy.